August 19, 2017 1:23 PM ET

Biotechnology

Company Overview of Q-Med AB

Key Executives for Q-Med AB

NameBoard RelationshipsTitleAge
Carina Bolin LL M.4 RelationshipsInterim Chief Executive Officer and General Counsel56
Bengt Ågerup Ph.D.18 RelationshipsFounder and Executive Chairman 74
Alexander Kotsinas M.Sc. (Ba and Econ.), M.Sc. (Eng.).3 RelationshipsChief Financial Officer and Vice President50

Q-Med AB Board Members*

NameBoard RelationshipsPrimary CompanyAge
Bengt Ågerup Ph.D. 18 Relationshipsnxt2b74
Anders Milton B.Sc. M.D., Ph.D. 31 RelationshipsVironova AB (publ)70
Bertil Hult M.Sc. (Ba and Econ.) 20 RelationshipsFörsäkringsaktiebolaget Skandia (publ)76
Tomas Nicolin 34 RelationshipsSkandinaviska Enskilda Banken AB (publ)63
Ulf Mattsson M.Sc. Econ. 67 RelationshipsEQT Partners AB53
View All Board Members

Q-Med AB Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee B.Sc. M.D., Ph.D.Anders Milton31 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
387.2K
Bonus
237.8K
Total Short Term Compensation
481.5K
Total Value of Options
18.6M
Compensation as of Fiscal Year
Q-Med AB CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

RHS Limited Appoints Alwin Hui as Chief Commercial Officer
August 18, 2017 3:43 AM ET
Immunocellular Therapeutics, Ltd. Announces Resignation of Mark A. Schlossberg and Gregg A. Lapointe from the Board of Directors
August 17, 2017 8:32 PM ET
Five Prime Therapeutics, Inc. Appoints Bryan Irving as Senior Vice President, Research, with Effect from September 1, 2017
August 17, 2017 8:05 PM ET
BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub; Appoints Michael Scott as Senior Vice President of Product Development and Toronto Operations
August 17, 2017 12:00 PM ET
PsiOxus Therapeutics Announce Two New Board Members
August 17, 2017 7:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Q-Med AB, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.